LONDON — The UK government announces it is buying millions of doses of new COVID-19 treatment pills as the Omicron variant takes hold, while cutting the isolation period for positive cases.
The government says it has signed deals to buy 4.25 million courses of two new antiviral drugs: Pfizer’s Ritonavir and US rival Merck/MSD’s Molnupiravir, which will be available early next year.
This comes on top of government announcements in October of the procurement of several hundreds of thousands of doses, and was hailed as a “mammoth deal” by Health Secretary Sajid Javid.
The UK has seen a surge in infections since Omicron became the dominant variant, with 90,629 cases reported yesterday. The country is one of the hardest hit in Europe, with a death toll of 147,433.
Prime Minister Boris Johnson has resisted calls to impose stricter virus restrictions over Christmas in England, unlike the devolved governments in other UK nations.
From today, those who have caught the virus but feel well can come out of self-isolation after seven days instead of 10, potentially allowing more to join family celebrations.
This rule only applies to people who have taken two negative lateral flow tests, NHS England says.
At the same time, UK leaders were expected to announce fresh virus measures for the post-Christmas period.
Large New Year’s Eve events have already been cancelled in London and Edinburgh.
Help us report truthfully on social media
As a multimedia journalist, my job is to take the quality, fact-based journalism produced by The Times of Israel newsroom and make it accessible across every platform — from Instagram posts to podcasts to short-form videos.
This is how many, especially young people, consume news these days. But misinformation is rampant on social media. Our team at ToI produces accurate, responsible short-form reporting on Israel and the Jewish world.
If you believe in the importance of factual social media journalism, please consider joining our reader support group, The Times of Israel Community. Your financial support is essential to sustain responsible multimedia reporting.
— Gabriella Jacobs, multimedia journalist
Support our work
Support our work
Already a member? Sign in to stop seeing this
You're a dedicated reader
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you,
David Horovitz, Founding Editor of The Times of Israel
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this